US BANCORP \DE\ - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$114,786
+104.5%
2,990
+1.0%
0.00%
Q2 2023$56,132
+20.6%
2,959
-1.4%
0.00%
Q1 2023$46,561
-11.3%
3,002
+1.5%
0.00%
Q4 2022$52,522
+556.5%
2,959
+114.9%
0.00%
Q3 2022$8,000
+166.7%
1,377
+113.2%
0.00%
Q2 2022$3,0000.0%646
+1.7%
0.00%
Q1 2022$3,000
-62.5%
635
-32.2%
0.00%
Q4 2021$8,000
-11.1%
937
-10.9%
0.00%
Q3 2021$9,0001,0520.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders